• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Campbell Appoints Carrie Anderson Chief Financial Officer

    1/25/23 4:30:00 PM ET
    $CPB
    $EMBC
    $IART
    Packaged Foods
    Consumer Staples
    Medical/Dental Instruments
    Health Care
    Get the next $CPB alert in real time by email

    Campbell Soup Company (NYSE:CPB) today announced the appointment of Carrie L. Anderson as Executive Vice President and Chief Financial Officer, effective Feb. 6.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005725/en/

    Carrie Anderson (Photo: Business Wire)

    Carrie Anderson (Photo: Business Wire)

    Anderson will lead Campbell's finance function, including controllership, corporate financial planning and analysis, corporate strategy and development, tax, treasury, internal audit, investor relations, transactional services and financial systems. She will report to Campbell's President and Chief Executive Officer Mark Clouse and become a member of the company's Operating Committee and a Corporate Officer. Anderson succeeds Mick Beekhuizen, who was appointed President of Campbell's Meals & Beverages division in November 2022.

    "I am delighted to welcome Carrie to our leadership team. She brings a wide range of diverse, strategic experience and financial discipline, and her expertise in capital management and deployment will help us continue to drive our growth plans and enhance our performance," said Clouse. "Her collaborative approach combined with a track record of driving transformation, delivering results and developing strong finance teams will be invaluable as we continue to build momentum in the business."

    Anderson brings a wealth of financial experience working in a variety of complex industries, as well as a background in manufacturing and engineering. She joins Campbell from Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, where she has served as Executive Vice President and Chief Financial Officer since 2019. Before Integra, Anderson spent seven years with Dover Corporation in several leadership roles, including Chief Accounting Officer/Corporate Controller, and Vice President and CFO for the company's engineered systems and printing and identification businesses. Previously, Anderson spent six years as Vice President and Chief Financial Officer of Delphi Product & Service Solutions, a division of Delphi Corporation. While at Delphi, she also held leadership positions in finance, treasury and investor relations. Anderson started her career with General Motors.

    Anderson earned her B.S. in chemical engineering from Purdue University and an MBA from Ball State University. She serves on the board of directors of Embecta Corp. (NASDAQ:EMBC) and is a member of its Audit and Nominating & Governance committees.

    About Campbell Soup Company

    For more than 150 years, Campbell (NYSE:CPB) has been connecting people through food they love. Generations of consumers have trusted Campbell to provide delicious and affordable food and beverages. Headquartered in Camden, N.J. since 1869, Campbell generated fiscal 2022 net sales of nearly $8.6 billion. Our portfolio includes iconic brands such as Campbell's, Cape Cod, Goldfish, Kettle Brand, Lance, Late July, Milano, Pace, Pacific Foods, Pepperidge Farm, Prego, Snyder's of Hanover, Swanson and V8. Campbell has a heritage of giving back and acting as a good steward of the environment. The company is a member of the Standard & Poor's 500 as well as the FTSE4Good and Bloomberg Gender-Equality Indices. For more information, visit www.campbellsoupcompany.com or follow company news on Twitter via @CampbellSoupCo.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230125005725/en/

    Get the next $CPB alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPB
    $EMBC
    $IART

    CompanyDatePrice TargetRatingAnalyst
    The Campbell's Company
    $CPB
    8/20/2025$33.00Neutral
    Analyst
    The Campbell's Company
    $CPB
    8/7/2025$34.00Overweight → Neutral
    Piper Sandler
    The Campbell's Company
    $CPB
    6/20/2025Buy → Hold
    Argus
    The Campbell's Company
    $CPB
    4/23/2025$36.00Sell
    UBS
    Embecta Corp.
    $EMBC
    4/10/2025$15.00Neutral
    Mizuho
    Integra LifeSciences Holdings Corporation
    $IART
    3/31/2025Hold → Buy
    Argus
    The Campbell's Company
    $CPB
    3/17/2025Overweight → Equal Weight
    Consumer Edge Research
    The Campbell's Company
    $CPB
    3/6/2025$48.00 → $37.00Overweight → Neutral
    Analyst
    More analyst ratings

    $CPB
    $EMBC
    $IART
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    EVP, Chief Financial Officer Cunfer Todd E was granted 73,467 shares (SEC Form 4)

    4 - CAMPBELL'S Co (0000016732) (Issuer)

    11/3/25 4:05:02 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    EVP, Chief People&Culture Ofcr Johnson May Diane covered exercise/tax liability with 17,088 shares, decreasing direct ownership by 17% to 82,006 units (SEC Form 4)

    4 - CAMPBELL'S Co (0000016732) (Issuer)

    11/3/25 4:03:56 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Jeffrey A bought $102,150 worth of shares (9,000 units at $11.35), increasing direct ownership by 28% to 41,086 units (SEC Form 4)

    4 - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Issuer)

    11/6/25 4:05:46 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $105,995 worth of shares (10,000 units at $10.60), increasing direct ownership by 13% to 86,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    5/23/25 4:35:56 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Director Melcher David F bought $177,646 worth of shares (13,000 units at $13.67), increasing direct ownership by 20% to 76,681 units (SEC Form 4)

    4 - Embecta Corp. (0001872789) (Issuer)

    2/25/25 4:26:16 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Campbell Soup with a new price target

    Analyst resumed coverage of Campbell Soup with a rating of Neutral and set a new price target of $33.00

    8/20/25 8:33:18 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Campbell Soup from Overweight to Neutral and set a new price target of $34.00

    8/7/25 7:33:36 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    Campbell Soup downgraded by Argus

    Argus downgraded Campbell Soup from Buy to Hold

    6/20/25 8:05:51 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Integra LifeSciences Holdings Corporation

    SCHEDULE 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/6/25 4:22:05 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    SEC Form DEFA14A filed by The Campbell's Company

    DEFA14A - CAMPBELL'S Co (0000016732) (Filer)

    10/31/25 4:11:15 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by Integra LifeSciences Holdings Corporation

    10-Q - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Filer)

    10/30/25 4:05:21 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

    PARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal fourth quarter and full year 2025 financial results and provide an operational update, including preliminary fiscal year 2026 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 25, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company's website at investors.embecta.com. A webcast replay of the c

    11/11/25 5:00:00 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

    PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce the FDA 510(k) clearance for use of its CUSA® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeries, including valve replacement and repair. In addition to cardiac surgery, the CUSA Clarity Ultrasonic Surgical Aspirator System is indicated for use in surgical procedures where fragmentation, emulsification and aspiration of soft and hard (e.g. bone) tissue is desirable, such as neuro

    11/11/25 4:15:00 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's Declares It's Officially Sides Season™ with 2025 State of the Sides Report and Limited-Edition Designer Drop

    The fourth annual report reveals side dishes continue to shine as Campbell's teams up with Cynthia Rowley and Kit Keenan to debut Campbell's Sides Collection CAMDEN, N.J., Nov. 6, 2025 /PRNewswire/ -- For over 150 years, Campbell's® hasn't just been part of holiday meals – it's helped define them. And during the holidays when loved ones gather, side dishes are always at the heart of the table. This Sides Season™, Campbell's is not only bringing the latest State of the Sides Report to the table, it's helping people show up with their favorite dishes in style with a first-of-its

    11/6/25 9:00:00 AM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Financials

    Live finance-specific insights

    View All

    embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

    PARSIPPANY, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal fourth quarter and full year 2025 financial results and provide an operational update, including preliminary fiscal year 2026 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 25, 2025. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company's website at investors.embecta.com. A webcast replay of the c

    11/11/25 5:00:00 PM ET
    $EMBC
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences Reports Third Quarter 2025 Financial Results

    PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025. Third Quarter 2025 Highlights Third quarter revenues of $402.1 million increased 5.6% on a reported basis and 5.0% on an organic basis compared to the prior year. Third quarter GAAP earnings per diluted share of $(0.07), compared to $(0.14) in the prior year. Adjusted earnings per diluted share of $0.54, compared to $0.41 in the prior year.Relaunch of PriMatrix® and Durepair® ahead of schedule, through dual sourcing supply strategy.Appointed Dr. Raymond Tur

    10/30/25 6:00:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025

    PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET. A live webcast will be available on the Investors section of the Company's website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of th

    10/15/25 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    $CPB
    $EMBC
    $IART
    Leadership Updates

    Live Leadership Updates

    View All

    Campbell's Appoints Todd Cunfer Chief Financial Officer

    Established Finance Leader Brings Over Two Decades of Food Industry Experience The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Todd Cunfer as Executive Vice President and Chief Financial Officer, effective Oct. 20, 2025. He will report to Campbell's President and Chief Executive Officer Mick Beekhuizen and become a member of the company's Operating Committee and an Executive Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251007967740/en/Todd Cunfer "I am excited to welcome Todd to the Campbell's team," said Beekhuizen. "With more than two decades of food industry experience, he brin

    10/7/25 4:30:00 PM ET
    $CPB
    $FRPT
    $HSY
    Packaged Foods
    Consumer Staples
    Specialty Foods

    Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer

    PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice president and chief medical officer. Dr. Turner brings more than 20 years of experience in clinical operations, having held senior leadership positions at some of the world's largest global MedTech companies. At Integra, Dr. Turner will lead worldwide medical affairs and clinical development activities including clinical research, clinical trial operations, evidence generation, medical safety and communications. In addition to his role with Integra, Dr. Turner will continue his clinical practice, providi

    9/22/25 8:30:00 AM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Campbell's Appoints Kelly L. Palumbo Senior Vice President, Controller and Chief Accounting Officer

    The Campbell's Company (NASDAQ:CPB) (Campbell's) today announced the appointment of Kelly L. Palumbo as Senior Vice President, Controller and Chief Accounting Officer, effective Sept. 22, 2025. She succeeds Stan Polomski who is being appointed to the newly created role of Senior Vice President, Business Process Optimization in the company's Enterprise Transformation Office. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250904240330/en/Kelly Palumbo Palumbo will lead the corporate controller function and oversee corporate accounting, financial reporting, planning and controls. She will report to Carrie Anderson, Campbell's Execu

    9/4/25 4:30:00 PM ET
    $CPB
    Packaged Foods
    Consumer Staples

    $CPB
    $EMBC
    $IART
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Integra LifeSciences Holdings Corporation

    SC 13G - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 5:20:30 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Integra LifeSciences Holdings Corporation

    SC 13G/A - INTEGRA LIFESCIENCES HOLDINGS CORP (0000917520) (Subject)

    11/12/24 12:54:20 PM ET
    $IART
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Embecta Corp.

    SC 13G/A - Embecta Corp. (0001872789) (Subject)

    11/8/24 10:57:43 AM ET
    $EMBC
    Medical/Dental Instruments
    Health Care